Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
about
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspectiveInfluenza vaccination in immunocompromised patients: efficacy and safety.Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients.Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients.Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patientsA prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation.Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant.The effect of rituximab on vaccine responses in patients with immune thrombocytopeniaGraft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune DisordersA randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.Influenza vaccination in the organ transplant recipient: review and summary recommendations.European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients.Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation.Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM).Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions.
P2860
Q28740919-D10D9023-85A7-4AF6-A9D2-C9F43A63591CQ30358640-5151C8EF-0374-48C5-AAC3-93972345AF58Q30373149-144EBE30-1A51-4E58-A55B-8402B2F85D47Q30400161-17BA6739-4125-45EB-BDD1-9B43E7AEBD36Q30408740-3A271072-F4E0-4E97-9739-8432B0C7552FQ30409959-53EDE293-ABFE-4B25-BAC2-BA23F975C6A7Q30412678-297BD9E6-03A9-4351-B8E4-B6EC6390BD64Q30413413-09710FE0-3B30-47B2-ADE7-B6EACCDBB535Q30418951-CA443B08-3340-4A05-BD41-FCBB2E189967Q30424791-F14C7FC0-E8C1-43A2-AFB2-EC0915096247Q33409067-353978DD-42B3-400A-8BC4-1D893358BC21Q35018548-B3B37EC2-11A1-4B79-84B6-1D0CAA053096Q35846308-5B67B3E4-4591-43D6-A07F-2CD2B3046F72Q36009655-43FAEB5A-357B-4437-9D96-68F6E41969E1Q36781782-B759DEE0-9C4D-439F-A62C-5FF0FDE02BDFQ36846282-84FD888A-4FB4-48AC-9F47-341EB1093083Q37940524-1B27DB71-FEB3-407A-9E84-1B2179E67C53Q38077827-19777C56-A765-4BD0-8B6F-FF45236FD8C3Q40306881-780634D4-0A36-4DB3-BCED-36D3FB0D5D48Q40413531-20CD210F-589A-4661-8417-0CFE4B96BA2AQ42224597-2DFC0347-2636-4AA2-8A44-1799FCE94A99Q44302778-173D25ED-7897-455F-BB32-4C929D7EE452
P2860
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Seroprotective titers against ...... ll transplantation recipients.
@ast
Seroprotective titers against ...... ll transplantation recipients.
@en
type
label
Seroprotective titers against ...... ll transplantation recipients.
@ast
Seroprotective titers against ...... ll transplantation recipients.
@en
prefLabel
Seroprotective titers against ...... ll transplantation recipients.
@ast
Seroprotective titers against ...... ll transplantation recipients.
@en
P2093
P2860
P50
P1476
Seroprotective titers against ...... ell transplantation recipients
@en
P2093
Corey S Cutler
Edwin P Alyea
John Koreth
Joseph H Antin
Kelly A Verrill
Lisa S Gagne
Nicolas C Issa
Philippe Armand
Robert J Soiffer
Vincent T Ho
P2860
P304
P356
10.1016/J.BBMT.2010.10.002
P577
2010-10-13T00:00:00Z